| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |